The medium and long-term debt of pharmaceutical firm Unimed listed on Tunisia stock exchange grew by 448% year to year in S1, 2019 to reach TND20.8 million.
The firm explains that during the period under review, it borrowed TND4.8 million from banks for its expansion project.
According to Moroccan media citing Charfeddine Ridha (photo), UNIMED’s managing director, an TND80 million-investment plan is announced for the expansion of the firms’ laboratories.
Despite the growth of its debt, Unimed’s turnover rose by 124% year on year to reach TND31.1 million thanks to its sales on local and foreign markets that quarter.
Chamberline MOKO
CCR-UEMOA presents mid-term review of private sector competitiveness efforts Reforms, AfCFTA trai...
Telecel Ghana to boost network investment by 150% in 2026 Expansion targets capacity, reliabi...
Togo parliament adopts WAEMU law against currency counterfeiting Bill defines offences including ...
This week, Africa is facing a mixed health situation. Namibia has declared an end to its mpox outbre...
Namibia and Russia agreed to expand cooperation across energy, mining, and agriculture. Both coun...
Maluku SEZ to receive river dock to boost logistics Saphir Ceramics funds dock to improve exports via river Facility supports growing industrial...
UNCDF, Co-op Bank Kenya sign guarantee to boost digital lending Risk-sharing aims expand financing access for startups, platforms Deal supports...
Nigeria considers increasing 75 MW electricity exports to Togo Talks focus on meeting rising demand and recent supply disruptions Expansion depends on...
Ghana to submit UN resolution on slave trade March 25 Draft seeks recognition as gravest crime against humanity Backed by AU, CARICOM; aims support...
Event highlights growing role of diaspora entrepreneurs across multiple sectors Networks support trade, investment and SME...
Afreximbank launches Impact Stories season two highlighting trade-driven transformations Series features projects across Africa and Caribbean, from...